MammaPrint
MammaPrint is a prognostic and predictive diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other parts of the body.
BluePrint
a molecular subtyping test, analyzes the activity of 80 genes to enable stratification of the tumor into one of the three following
Polyerga Tab.
It is a chemotherapy supplement for malignant tumor disease approved by the Korea Food and Drug Administration as an anticancer immunomodulator.
Ruconest Inj.
Acute seizure treatment for hereditary angioedema in adults except oropharyngeal and larynx.
IMMUNOSCORE®
Immunoscore is a method to estimate the prognosis of cancer patients, based on the immune cells that infiltrate cancer and surround it. Its provides better prognostic information than the current staging system, TNM.
Neoscope2020
The NeoScope Family of Rigid, Semi-Rigid and Flexible Digital Endoscopic Video system consists of a Single Use, Digital Video Endoscopes with CMOS imaging sensor and Built-in LED light source, that can be powered by commercially available Desktops, Laptops and Tablet computers.
Preparing
Preparing
